In this new issue of our Healthcare & Competition Newsletter, we provide an overview of the most relevant news for this sector on the authorities and courts’ front. In particular, we revisit the highly controversial Grail/Illumina case which seems to have a promising future in the podium of European competition law sagas.
Also, very specially, we proudly present two cases in which we successfully advised clients on antitrust matters: (i) the first European fine for sham litigation, in which we acted as complainants; and (ii) the conventional termination of a Spanish antitrust file referred to vertical practices.
We will close the Newsletter with several short highlights that may deserve a closer look in the near future.
